Get the Stockscreener App
4.02
1.01%
0.04
Trisalus Life Sciences Inc stock is traded at $4.02, with a volume of 14,379.
It is up +1.01% in the last 24 hours and down -11.65% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$3.98
Open:
$4
24h Volume:
14,379
Relative Volume:
0.32
Market Cap:
$121.96M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.50%
1M Performance:
-11.65%
6M Performance:
-58.21%
1Y Performance:
-13.36%
1-Day Range:
$4.00
$4.10
1-Week Range:
$3.7758
$4.10
52-Week Range:
$3.32
$10.42
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Trisalus Life Sciences Inc Stock (TLSI) Latest News
TriSalus Life Sciences, Inc. Announces Resignation and Departure of Board Member and Chief Medical Officer - Defense World
TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call - BioSpace
Northland Securities Begins Coverage on TriSalus Life Sciences (NASDAQ:TLSI) - Defense World
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Up 21.3% in October - MarketBeat
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Northland Capmk Upgrades TriSalus Life Sciences (NASDAQ:TLSI) to "Strong-Buy" - MarketBeat
Northland initiates TriSalus shares with outperform, cites sales growth - Investing.com India
Northland initiates TriSalus shares with outperform, cites sales growth By Investing.com - Investing.com South Africa
TriSalus Life Sciences (NASDAQ:TLSI) Coverage Initiated by Analysts at Northland Securities - MarketBeat
Northland Capital Markets Initiates Coverage of TriSalus Life Sciences (TLSI) with Outperform Recommendation - MSN
ALUS presents the 2024 Dave Reid Award to François Allard - GlobeNewswire Inc.
Riad Salem Joins Scientific Advisory Board Of TriSalus Life Sciences - MPO-mag
TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit - BioSpace
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Short Interest Up 62.5% in September - MarketBeat
Bluefin Capital Management LLC Purchases New Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) - Defense World
TriSalus Life Sciences, Inc. Announces Appointment of Riad Salem to its Scientific Advisory Board - Marketscreener.com
TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board - BioSpace
TriSalus Life Sciences adds oncology expert to SAB By Investing.com - Investing.com South Africa
TriSalus Life Sciences adds oncology expert to SAB - Investing.com India
Magnetar Financial LLC Has $1.05 Million Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSIW) - Defense World
Terrain Minerals Welcomes New Major Investor - TipRanks
TrivarX Boosts Board with Healthcare Expertise - TipRanks
TScan therapeutics director buys $26,450 in company stock By Investing.com - Investing.com UK
Progeny 3 Inc. Raises Stock Holdings in Sixth Street Specialty Lending, Inc. (NYSE:TSLX) - Defense World
940,831 Shares in TScan Therapeutics, Inc. (NASDAQ:TCRX) Purchased by Great Point Partners LLC - Defense World
Telesis Bio Inc (TBIO) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - ForexTV.com
TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com
Investing in Telesis Bio Inc (TBIO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Farallon Capital Management LLC Buys Shares of 2,000 TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Trupanion: Great Business, But It Is Time To Cash Out (Rating Downgrade) - Seeking Alpha
TriSalus reports breakthrough in liver tumor treatment By Investing.com - Investing.com Canada
TriSalus reports breakthrough in liver tumor treatment - Investing.com India
Hood River Capital Management LLC Acquires New Position in TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World
Keeping an Eye on Tourmaline Bio Inc (TRML) After Insider Trading Activity - Knox Daily
Financial Metrics Check: Traws Pharma Inc. (TRAW)’s Ratios for Trailing Twelve Months - The Dwinnex
TriSalus: PEDD method via TriNav Infusion System aided penetration of GM - TipRanks
TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System - Business Wire
35,000 Shares in Trupanion, Inc. (NASDAQ:TRUP) Purchased by Dalton Investments Inc. - MarketBeat
Inspire Investing LLC Makes New $772,000 Investment in Transcat, Inc. (NASDAQ:TRNS) - MarketBeat
Texas Permanent School Fund Corp Has $1.08 Million Stake in Trupanion, Inc. (NASDAQ:TRUP) - Defense World
Trupanion (NASDAQ:TRUP) Shares Gap Up on Analyst Upgrade - MarketBeat
Bank of America Raises Trupanion (NASDAQ:TRUP) Price Target to $56.00 - MarketBeat
Telesis Bio Inc (TBIO) can make a big difference with a little luck - SETE News
Highbridge Capital Management LLC Buys Shares of 214,545 TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - MarketBeat
Contrasting Cerus (NASDAQ:CERS) & TriSalus Life Sciences (NASDAQ:TLSI) - Defense World
Traws Pharma Announces Key Approvals and Reverse Stock Split at 2024 Special Meeting - MyChesCo
Blair William & Co. IL Decreases Stock Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Ratios in Focus: Analyzing Telesis Bio Inc (TBIO)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Highbridge Capital Management LLC Invests $1.18 Million in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World
TriSalus Life Sciences (NASDAQ:TLSI) Now Covered by Analysts at Oppenheimer - Defense World
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Trisalus Life Sciences Inc Stock (TLSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Szela Mary T | CEO AND PRESIDENT |
Sep 13 '24 |
Buy |
4.97 |
7,295 |
36,255 |
384,677 |
| Szela Mary T | CEO AND PRESIDENT |
Sep 10 '24 |
Buy |
4.97 |
5,000 |
24,850 |
369,862 |
| Martin George Kelly | Director |
Aug 28 '24 |
Sale |
5.50 |
9 |
50 |
247,176 |
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):